Talence, France

Michel Hospital

This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Hospital. Retrieved from https://idiyas.com/inventor/michel-hospital

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Hospital – Innovator in Hexapeptides

Introduction

Michel Hospital, an inventive mind based in Talence, France, has made significant contributions to the field of biochemistry through his patented work. With a single patent to his name, he has demonstrated an ability to innovate in specialized areas of pharmaceutical research.

Latest Patents

Michel Hospital holds a patent for novel hexapeptides characterized by the unique formula that has potential applications in various therapeutic areas. His work focuses on advancing our understanding of these peptides and their possible benefits for health and disease management.

Career Highlights

As a member of Roussel Uclaf, Michel has been at the forefront of pharmaceutical development. His career reflects a commitment to innovation and research, paving the way for advancements in peptide technology and its applications.

Collaborations

Throughout his career, Michel Hospital has collaborated with notable colleagues such as Jean-Claude Gasc and Serge Geoffre. Together, they have contributed to the advancement of scientific knowledge and the development of new pharmaceutical products.

Conclusion

Michel Hospital exemplifies the spirit of innovation that drives progress in the pharmaceutical industry. His work with hexapeptides not only enhances our understanding of biochemistry but also represents the potential for healing and advancement in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…